9.3 Institutional & Health Care Facility Pharmacy Practice

Institutional & Health Care Facility Pharmacy Practice

Institutional pharmacy practice encompasses the provision of pharmaceutical care within hospitals, health systems, long-term care facilities, inpatient hospices, and rehabilitation centers. In New Jersey, pharmaceutical services in health care facilities are governed by N.J.A.C. 13:39-9, operating in tandem with hospital licensing mandates enforced by the New Jersey Department of Health (NJDOH) and federal standards established by the Centers for Medicare & Medicaid Services (CMS). MPJE candidates must understand the governance hierarchy, unit-dose dispensing systems, automated dispensing technology, prospective order review safeguards, crash cart protocols, and strict after-hours emergency entry procedures.

---

Administrative Governance: The Director of Pharmacy

Under N.J.A.C. 13:39-9.3, every institutional pharmacy practice site must be directed by a licensed New Jersey pharmacist who serves as the Director of Pharmacy (the institutional equivalent of the Pharmacist-in-Charge, RPIC). The Director of Pharmacy holds operational, administrative, and legal responsibility for the entirety of the pharmaceutical distribution pipeline within the institution.

Core Responsibilities of the Director of Pharmacy

• Continuous Supervision: Directs and supervises all professional, clinical, and supportive operations of the pharmacy, ensuring continuous adherence to state pharmacy rules and hospital bylaws.
• Policy and Procedure Manual: Authors, implements, and maintains a comprehensive written Policy and Procedure Manual governing drug procurement, unit-dose packaging, IV compounding, investigational drugs, recall protocols, automated systems, and controlled substance auditing. This manual must undergo formal annual review and documentation.
• Interdisciplinary Committee Representation: Serves as a key voting member of the Pharmacy and Therapeutics (P&T) Committee, the Institutional Review Board (IRB), and the Hospital Quality & Patient Safety Committee.
• Formulary Management: Directs the institutional drug formulary, establishing evidence-based drug selection, therapeutic interchange protocols, and automatic drug stop orders.

                         INSTITUTIONAL PHARMACY GOVERNANCE
                                         │
               ┌─────────────────────────┴─────────────────────────┐
               ▼                                                   ▼
   Director of Pharmacy (RPIC)                       Pharmacy & Therapeutics (P&T)
  • Administrative & operational head               • Approves institutional formulary
  • Annual Policy & Procedure review                • Designs automatic stop order policies
  • Oversight of ADCs & cleanrooms                  • Authorizes emergency kit drug lists
  • Investigational drug accountability             • Approves emergency override list

---

Inpatient Medication Distribution Systems

Modern hospital pharmacy practice minimizes medication administration errors through centralized and decentralized unit-dose architectures (N.J.A.C. 13:39-9.13):

Unit-Dose Packaging and Labeling Standards

Medications distributed within an institutional facility must be dispensed in unit-dose packaging whenever clinically feasible. Each individual unit-dose package (blister, pouch, oral syringe) must be labeled with:

1. The generic name and/or brand name of the medication.
2. The strength and dosage form.
3. The manufacturer's name and lot/control number.
4. The facility's assigned internal packaging batch number (if repackaged internally).
5. An appropriate Beyond-Use Date (BUD) or expiration date calculated in accordance with USP standards.

Automated Dispensing Cabinets (ADCs - Pyxis, Omnicell, AcuDose)

Pursuant to N.J.A.C. 13:39-9.17, automated medication systems deployed on patient care units must operate under strict electronic security controls:

• Profile-Driven Dispensing: ADCs must interface directly with the hospital's pharmacy information system. A nurse cannot access a patient's drawer or unlock a medication cubie until a pharmacist has reviewed and verified the order on the electronic patient profile.
• Multi-Factor Access: Access requires unique user identification, involving biometric scanning (fingerprint) or multi-factor badge-and-password credentials.
• Blind Controlled Substance Counts: When dispensing or restocking controlled dangerous substances, the ADC must require a "blind count"—the user must count and input the physical quantity in the drawer without the system displaying the expected inventory on screen.
• Discrepancy Auditing: ADC inventory discrepancies must be investigated and resolved before the end of each shift or within 24 hours by pharmacy and nursing leadership.

---

Prospective Order Review & The Emergency Override Protocol

Under N.J.A.C. 13:39-9.11, patient safety in an institutional setting relies heavily on the pharmacist serving as an independent clinical checkpoint before drug administration occurs.

The Prospective Review Mandate

Before any medication dose is administered to an inpatient, a licensed pharmacist must conduct a prospective drug utilization review (DUR) of the prescriber's order against the patient's electronic medical record (eMAR), evaluating:

• Patient allergies and adverse drug reaction history.
• Therapeutic appropriateness, dose, frequency, and route of administration.
• Drug-drug interactions, drug-food interactions, and contraindications.
• Duplicate therapies across inpatient orders.
• Organ function adjustments (e.g., renal clearance using CrCl for renally eliminated drugs).

The Emergency Override Exception

The only exception to the prospective review requirement occurs in a documented clinical emergency. Under N.J.A.C. 13:39-9.11, nursing staff may bypass prospective pharmacist verification and remove medications via an emergency override function on the ADC under strict regulatory conditions:

1. Clinical Justification: Override is limited to situations where waiting for prospective pharmacist review would result in severe patient harm, permanent morbidity, or death (e.g., cardiopulmonary arrest, acute malignant hyperthermia, rapid sequence intubation, status epilepticus, acute anaphylaxis).
2. P&T Approved Formulary: The medications accessible via override must be pre-approved by the P&T Committee and restricted to emergency drugs (e.g., epinephrine, naloxone, atropine, dextrose 50%, succinylcholine).
3. Restricted Locations: Overrides are typically configured in high-acuity areas (Emergency Departments, Trauma Bays, Operating Suites, Intensive Care Units, Cardiac Catheterization Labs).
4. Mandatory Retrospective Reconciliation: All emergency override transactions must generate an immediate electronic audit log and undergo retrospective pharmacist review and clinical reconciliation within 24 hours.

                        INPATIENT DRUG ORDER REVIEW WORKFLOW
                                         │
               ┌─────────────────────────┴─────────────────────────┐
               ▼                                                   ▼
       Standard Medication Order                        Emergency Clinical Event
  • Prescriber enters CPOE order                      • Acute crisis (Code Blue, Anaphylaxis)
  • Pharmacist conducts prospective DUR               • Prospective review would harm patient
  • Order verified in Pharmacy System                 • Nurse executes ADC EMERGENCY OVERRIDE
  • ADC unlocks specific medication cubie             • Immediate drug administration
  • Nurse administers dose to patient                 • Retrospective DUR within 24 hours

---

Automatic Stop Order Policies (N.J.A.C. 13:39-9.12)

To prevent the open-ended, unmonitored administration of potent, dangerous, or toxic medications, New Jersey administrative law mandates that every health care facility establish formal written Automatic Stop Order Policies.

Targeted Drug Classes

If a prescriber writes an inpatient medication order without specifying an exact duration or total number of doses, the automatic stop order takes effect for:

• Broad-Spectrum Antibiotics & Antimicrobials: Typically subject to a 48-hour to 72-hour automatic stop order, enforcing clinical culture-and-susceptibility reassessment and antimicrobial stewardship.
• Parenteral Anticoagulants & Thrombolytics: Heparin infusions, therapeutic low-molecular-weight heparins, and direct thrombin inhibitors.
• Controlled Dangerous Substances (CDS): Schedule II, III, and IV opioid analgesics, sedatives, and hypnotics.
• Corticosteroids & Biological Immunosuppressants: High-dose systemic steroids.

Operational Notification Protocol

The pharmacy system must issue an electronic warning or written alert to the attending physician and nursing staff prior to the expiration of the automatic stop order window (e.g., 24 hours prior), allowing the physician to re-evaluate the patient's clinical response and actively renew the order if ongoing therapy is warranted.

---

Emergency Kits & Crash Carts (N.J.A.C. 13:39-9.16)

To ensure immediate pharmacological response during medical emergencies across nursing units, the institutional pharmacy supplies and maintains emergency drug kits and cardiac arrest crash carts:

• P&T Committee Approval: The exact drug inventory, quantities, strengths, and dosage forms contained within emergency kits and crash carts must be determined jointly by the Director of Pharmacy and the P&T Committee.
• Physical Tamper-Evident Seals: Every emergency kit and crash cart drawer must be secured with a uniquely numbered, breakable tamper-evident plastic seal or electronic lock.
• Exterior Expiration Labeling: The exterior of each sealed kit or cart must bear an inspection tag displaying: (1) the serial number of the tamper-evident seal, and (2) the earliest expiration date of any single medication contained inside.
• Immediate Replenishment Protocol: As soon as an emergency kit or crash cart seal is broken (or immediately following a code event), nursing staff must notify the pharmacy. Pharmacy personnel must immediately retrieve the opened cart, replace used items, verify contents, apply a new numbered tamper-evident seal, and update the exterior expiration tag.

---

After-Hours Pharmacy Coverage & Emergency Entry Protocols

While major tertiary hospitals maintain 24-hour on-site pharmacy coverage, smaller community hospitals, specialty surgery centers, and rehabilitation facilities may close their physical pharmacy departments overnight. Under N.J.A.C. 13:39-9.14, when the institutional pharmacy is closed and a pharmacist is not physically on the premises, the facility must enforce strict protocols to ensure emergency medication availability:

Tier 1: External Night Cabinets

• Physical Location: Secure, locked automated cabinets or drug supply boxes located outside the physical pharmacy department (e.g., in a secure nursing administration vestibule).
• Authorized Access: Accessible only by authorized licensed registered nurses using unique credentials.
• Contents: Pre-packaged, unit-of-use emergency medications approved by the Director of Pharmacy and P&T Committee.
• Logging: All removals must be electronically or manually documented (patient name, nurse, drug, dose, date/time).
• Reconciliation: A licensed pharmacist must review all night cabinet transaction logs within 24 hours of pharmacy reopening.

Tier 2: Emergency Physical Entry Into the Closed Pharmacy

If an urgently required medication is NOT available in night cabinets, crash carts, or floor stock, physical entry into the locked pharmacy is permitted under strict statutory constraints (N.J.A.C. 13:39-9.14):

[!CAUTION] High-Yield MPJE Trap: A staff nurse can NEVER enter a closed institutional pharmacy alone. Entry is strictly limited to one designated supervisory RN per shift, and that nurse must be accompanied by an escort (security guard or licensed professional). Furthermore, the pharmacist must reconcile the entry within 24 hours.

---

Practical Legal Scenario & Exam Pitfalls

Scenario: At 2:30 AM at Hope Memorial Hospital, the inpatient pharmacy is closed. In the Intensive Care Unit, a patient experiences acute hemodynamic collapse secondary to septic shock. The ICU physician orders an urgent infusion of vasopressin. The drug is not stocked in the unit's ADC or the external night cabinet. Staff Nurse Sarah takes the master pharmacy key from the nursing station, enters the dark pharmacy alone, takes three vials of vasopressin from the shelf, leaves a post-it note on the counter with the patient's room number, and returns to the ICU. The following day at 4:00 PM, the morning pharmacist arrives, throws away the post-it note, and updates the inventory without completing an audit report.

Legal Analysis:

1. Illegal Entry Personnel: Nurse Sarah violated N.J.A.C. 13:39-9.14. A staff nurse cannot enter the closed pharmacy. Only the designated supervisory registered nurse for that shift is legally authorized to enter.
2. Lack of Mandatory Escort: Entering alone violates state law. The supervisory nurse must be accompanied by a security guard or another licensed healthcare professional.
3. Improper Entry Documentation: Leaving an informal post-it note violates the statutory entry log mandate, which requires documenting the exact date, time, patient ID, prescriber, drug name, strength, dosage form, quantity, and signatures of both the nurse and the escort.
4. Pharmacist Reconciliation Failure: The morning pharmacist committed a regulatory violation by discarding the note and failing to conduct a formal retrospective audit and verification of the emergency entry within 24 hours.